IMI International Medical Innovations

IMI International Medical Innovations

IMI International Medical Innovations, established in 1992,is a
predictive medicine company dedicated to developing innovative
products for the early detection and monitoring of life-
threatening diseases, particularly cancer and cardiovascular
disease.

IMIs particular expertise is its ability to identify novel
predictive medicine technologies that are in the early stages of
development. The company efficiently completes the product
development, clinical and regulatory requirements and finally,
exploits these technologies for commercial success. IMI has
consistently demonstrated an ability to complete this process in
a cost effective and timely manner.

The Company will partner with major diagnostic or pharmaceutical
companies to manufacture and or market the products on a global
basis.

Company Details

Year Established: 1992

Number of Employees: 15

Company Information

Ron Hosking
Title: Vice President
Area of Responsibility: Finance/Accounting
Telephone: (416) 222-3449
Fax: (416) 222-4533
Email: Click Here

Brent Norton Md, Mba
Title: Chief Executive Officer
Area of Responsibility: Management Executive
Telephone: (416) 222-3449
Fax: (416) 222-4533
Email: Click Here

Andrew Weir
Title: Director
Telephone: (416) 222-3449
Fax: (416) 222-4533
Email: Click Here

Tim Currie
Title: Director
Area of Responsibility: Domestic Sales & Marketing
Telephone: (416) 222-3449
Fax: (416) 222-4533
Email: Click Here

Mike Evelegh
Title: Vice President
Area of Responsibility: Research/Development/Engineering
Telephone: (416) 222-3449
Fax: (416) 222-4533
Email: Click Here

Products

Cholesterol 1,2,3

Lungalert
A non-invasive sputum based test for the early detection of lung cancer

Colorectalert
A mucous based test for the early detection of colorectal cancer

Prostate Cancer
A non-invasive test for the early detection of prostate cancer

Breast Cancer Test

Services